| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,985,200 | 2,916,700 | 4,004,900 | 4,112,500 | | Cost of Revenue | 1,561,100 | 2,341,900 | 3,113,500 | 3,202,200 | | | Gross Profit | 424,100 | 574,800 | 891,400 | 910,300 | | | Operating Expenses | | Research Development | 52,300 | 80,100 | 88,100 | 90,700 | | Selling General and Administrative | 109,700 | 121,500 | 147,200 | 157,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 25,000 | 26,900 | 34,200 | 24,400 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 237,100 | 346,300 | 621,900 | 637,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | 15,200 | 21,900 | 24,600 | | Earnings Before Interest And Taxes | 245,100 | 361,500 | 643,800 | 662,300 | | Interest Expense | 208,500 | 195,700 | 215,200 | 216,300 | | Income Before Tax | 36,600 | 165,800 | 428,600 | 446,000 | | Income Tax Expense | 10,300 | 52,700 | 129,600 | 132,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26,300 | 113,100 | 299,000 | 313,500 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26,300 | 113,100 | 299,000 | 313,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26,300 | $113,100 | $299,000 | $313,500 |
|
0.45% Nasdaq 
0.20%
Income Statement
